| Kasey Payne Thrasher, RN | |
|
250 Bray St, Athens, GA 30601-2203 | |
| (706) 389-6789 | |
| Not Available |
| Full Name | Kasey Payne Thrasher |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 250 Bray St, Athens, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376273045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN239508 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kasey Payne Thrasher, RN 115 Discovery Trl, Athens, GA 30605-4701 Ph: (706) 614-0849 | Kasey Payne Thrasher, RN 250 Bray St, Athens, GA 30601-2203 Ph: (706) 389-6789 |
News Archive
The refunds are required under the health law when insurers spend less than 80 to 85 percent of health care premiums for medical care. Florida consumers will receive the biggest rebates, with $41.7 million returned, according to government data.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
"One in 10 adults will have diabetes by 2030, posing a huge challenge to health care systems around the world, according to a report" released by the International Diabetes Federation to coincide with World Diabetes Day on Monday, Reuters reports.
ChemoCentryx, Inc., today announced that it reported one-year results from the Company's PROTECT-1 Study (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN™ (CCX282-B) in patients with moderate-to-severe Crohn's disease. Traficet-EN, an orally bioavailable CCR9-specific chemokine receptor antagonist showed clinical efficacy in a 12-week Induction period, as well as a 36-week Maintenance period.
Canadian girls report higher levels of emotional problems and lower levels of emotional well-being and life satisfaction, while boys tend to experience more behavioural problems and demonstrate less prosocial behavior, a new Queen's University-led national study of youth health behavior shows.
› Verified 6 days ago
Fanie Wehmanen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 706-612-6995 Fax: 706-369-6328 | |
Janet Robison Avant, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9739 | |
Marjorie Spencer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mr. Vito Cortese Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 855-333-9544 | |
Richard Cereneche, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 195 Miles St, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mary Donna Hall, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-0333 Fax: 706-542-9693 | |
Tiny Stephens, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 675 College Ave, Athens, GA 30601 Phone: 706-546-5526 |